ArticleJornal vascular brasileiro2019
Limitations of VEINES QOL/SYM for discriminating chronic venous insufficiency severity.
Article in Jornal vascular brasileiro, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07793630 (Comparison Between Isolated Foam Sclerotherapy and Foam Sclerotherapy Combined With Transdermal Laser for the Treatment of Reticular Veins and Telangiectasias), which is not on this map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Comparison Between Isolated Foam Sclerotherapy and Foam Sclerotherapy Combined With Transdermal Laser for the Treatment of Reticular Veins and Telangiectasias: A Prospective Randomized Clinical Trial
Who cites it
4 citing papers in PubMed, 7 citations in OpenAlex.
- A randomized clinical trial of isolated ambulatory phlebectomy versus saphenous thermal ablation with concomitant phlebectomy (SAPTAP Trial).The British journal of surgery · 2023Trial
- Treatments for symptomatic class I patients in CEAP classification with saphenous vein reflux: A pilot study.Journal of vascular surgery. Venous and lymphatic disorders · 2023Article
- Analysis of data with dependent measures in clinical and experimental studies.Jornal vascular brasileiro · 2023Article
- Reliability and validity of specific quality of life assessment questionnaires related to chronic venous insufficiency: a systematic review.Jornal vascular brasileiro · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Venous Insufficiency Epidemiological and Economic Study - Quality of Life/Symptoms (VEINES-QOL / Sym) questionnaire was developed to evaluate the quality of life of individuals with chronic venous insufficiency (CVI), but it has shown limited sensitivity for discriminating between people with different of disease severity.
objectivesa) to propose a new formula for calculating the VEINES-QOL/Sym score and to evaluate whether this new score is capable of discriminating disease severity; and b) to evaluate the association between VEINES-QOL/Sym scores and disease severity.
methodsNinety-eight participants with CVI of both sexes, aged 60.73 ± 14.11 years, answered the Portuguese Brazilian version of the VEINES-QOL/Sym questionnaire. The new score was calculated by transforming the original scores to a 0 to 100 scale. Discriminant analysis was used to test the capability of the original and modified VEINES-QOL/Sym scores to discriminate between and correctly classify groups characterized by the clinical, etiological, anatomical and pathophysiological classification (CEAP). Alpha of 5% was defined as the cutoff for significance.
resultsThere were no significant differences between CEAP groups in terms of the original or modified VEINES-QOL/Sym scores. Discriminant analysis was also unable to correctly classify CEAP groups, using either original or modified scores. Furthermore, there were no associations between CEAP classifications and scores obtained using the questionnaire.
conclusionsThe VEINES-QOL/Sym proved to have limitations for assessment of the quality of life and symptomatology of people with CVI at different stages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.